All Cases

Pre-commercialization and Launch Strategy

Identification of stakeholder-specific value propositions for a mid-size pharma company launching a therapy for a Lupus

Evaluated the global strategic launch plan and tailored it to fit the needs of the local marketplace, maximizing the patient pool touched by commercialization efforts

Assessed challenges to improve the quality of multiple sclerosis care in LATAM for a large pharmaceutical company looking to publish a position paper to guide the improvement of care for these patients

Developed regional market access strategies in several emerging markets to ensure strong market access for our multinational pharmaceutical company client

Estimated NSCLC burden in Mexico based on RWE to inform clinical management and drive market share of more effective therapies

Companion diagnostic strategy for launch of novel biomarker-driven oncology drug

Prioritization of tumor types for a tumor agnostic oncology asset to focus promotional efforts

Characterized the KOL and CoE Landscape for a pediatric dysregulation syndrome to support pre-commercialization planning at a mid-sized pharmaceutical company

Assessed the burden of inherited retina diseases to provide several emerging markets with policy-informing data and financial models to raise awareness of the burden of these diseases

Characterized potential adoption challenges for a developmental allergic conjunctivitis product to facilitate strategic commercialization planning at a mid-sized ophthalmology company